Key result
Extracorporeal membrane oxygenation (ECMO) was successfully applied as a life-sustaining therapy in a 65-year-old woman with severe pulmonary hemorrhage secondary to granulomatosis with polyangiitis.
Why the study?
Does ECMO improve survival in a patient with acute respiratory failure due to massive pulmonary hemorrhage secondary to granulomatosis with polyangiitis?
Case Report (n=1)
Does ECMO improve survival in a patient with acute respiratory failure due to massive pulmonary hemorrhage secondary to granulomatosis with polyangiitis?
ECMO can be successfully used as a life-saving bridge to disease control in patients with severe pulmonary hemorrhage secondary to granulomatosis with polyangiitis, despite concerns about bleeding risks.
May support ECMO as bridge in GPA hemorrhage despite bleeding risks; single case leaves open survival benefit.
Extracorporeal membrane oxygenation (ECMO) is increasingly applied in adults with acute refractory respiratory failure that is deemed reversible. Bleeding is the most frequent complication during ECMO support. Severe pre-existing bleeding has been considered a contraindication to ECMO application. Nevertheless, there are cases of successful ECMO application in patients with multiple trauma and hemorrhagic shock or head trauma and intracranial hemorrhage. ECMO has proved to be life-saving in several cases of life-threatening respiratory failure associated with pulmonary hemorrhage of various causes, including granulomatosis with polyangiitis (Wegener's disease). We successfully applied ECMO in a 65-year-old woman with acute life-threatening respiratory failure due to diffuse massive pulmonary hemorrhage secondary to granulomatosis with polyangiitis, manifested as severe pulmonary-renal syndrome. ECMO sustained life and allowed disease control, together with plasmapheresis, cyclophosphamide, corticoids, and renal replacement therapy. The patient was successfully weaned from ECMO, extubated, and discharged home. She remains alive on dialysis at 17 months follow-up.
No takes yet. Share an insight, caveat, or question.
Zarogoulidis et al. (2013) conducted a case report in Pulmonary hemorrhage secondary to granulomatosis with polyangiitis (n=1). Extracorporeal membrane oxygenation (ECMO) was evaluated on Survival and disease control. Extracorporeal membrane oxygenation (ECMO) was successfully applied as a life-sustaining therapy in a 65-year-old woman with severe pulmonary hemorrhage secondary to granulomatosis with polyangiitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: